PROCESS FOR THE PURIFICATION OF MONTELUKAST

PROCESS FOR THE PURIFICATION OF MONTELUKAST

It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic sol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GASANZ GUILLEN YOLANDA, TALAVERA ESCASANY PEDRO, MONSALVATJE LLAGOSTERA MONTSERRAT
Format: Patent
Sprache:eng ; slv
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GASANZ GUILLEN YOLANDA
TALAVERA ESCASANY PEDRO
MONSALVATJE LLAGOSTERA MONTSERRAT
description It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic solvent and water at specific ranges of pH and temperature which depend on the type of impurities to remove. In particular, it comprises at least one wash of an aqueous phase containing crude Montelukast in salt form with an organic solvent, at a pH comprised between 12.0 and 13.5; and optionally one or more washes of the resulting aqueous phase with an organic solvent at a pH comprised between 8.5 and 10.0. Montelukast is recovered by acidification at a pH comprised between 4.5 and 8.0 and solvent extraction, and is isolated either as acid or in salt form.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2066638TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2066638TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2066638TT13</originalsourceid><addsrcrecordid>eNrjZNAOCPJ3dg0OVnDzD1II8XBVCAgN8nTzdHYM8fT3U_B3U_D19wtx9Qn1dgwO4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGeRgZmZmbGFiEhhsbEqAEAkL8llg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESS FOR THE PURIFICATION OF MONTELUKAST</title><source>esp@cenet</source><creator>GASANZ GUILLEN YOLANDA ; TALAVERA ESCASANY PEDRO ; MONSALVATJE LLAGOSTERA MONTSERRAT</creator><creatorcontrib>GASANZ GUILLEN YOLANDA ; TALAVERA ESCASANY PEDRO ; MONSALVATJE LLAGOSTERA MONTSERRAT</creatorcontrib><description>It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic solvent and water at specific ranges of pH and temperature which depend on the type of impurities to remove. In particular, it comprises at least one wash of an aqueous phase containing crude Montelukast in salt form with an organic solvent, at a pH comprised between 12.0 and 13.5; and optionally one or more washes of the resulting aqueous phase with an organic solvent at a pH comprised between 8.5 and 10.0. Montelukast is recovered by acidification at a pH comprised between 4.5 and 8.0 and solvent extraction, and is isolated either as acid or in salt form.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110630&amp;DB=EPODOC&amp;CC=SI&amp;NR=2066638T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110630&amp;DB=EPODOC&amp;CC=SI&amp;NR=2066638T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GASANZ GUILLEN YOLANDA</creatorcontrib><creatorcontrib>TALAVERA ESCASANY PEDRO</creatorcontrib><creatorcontrib>MONSALVATJE LLAGOSTERA MONTSERRAT</creatorcontrib><title>PROCESS FOR THE PURIFICATION OF MONTELUKAST</title><description>It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic solvent and water at specific ranges of pH and temperature which depend on the type of impurities to remove. In particular, it comprises at least one wash of an aqueous phase containing crude Montelukast in salt form with an organic solvent, at a pH comprised between 12.0 and 13.5; and optionally one or more washes of the resulting aqueous phase with an organic solvent at a pH comprised between 8.5 and 10.0. Montelukast is recovered by acidification at a pH comprised between 4.5 and 8.0 and solvent extraction, and is isolated either as acid or in salt form.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAOCPJ3dg0OVnDzD1II8XBVCAgN8nTzdHYM8fT3U_B3U_D19wtx9Qn1dgwO4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGeRgZmZmbGFiEhhsbEqAEAkL8llg</recordid><startdate>20110630</startdate><enddate>20110630</enddate><creator>GASANZ GUILLEN YOLANDA</creator><creator>TALAVERA ESCASANY PEDRO</creator><creator>MONSALVATJE LLAGOSTERA MONTSERRAT</creator><scope>EVB</scope></search><sort><creationdate>20110630</creationdate><title>PROCESS FOR THE PURIFICATION OF MONTELUKAST</title><author>GASANZ GUILLEN YOLANDA ; TALAVERA ESCASANY PEDRO ; MONSALVATJE LLAGOSTERA MONTSERRAT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2066638TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GASANZ GUILLEN YOLANDA</creatorcontrib><creatorcontrib>TALAVERA ESCASANY PEDRO</creatorcontrib><creatorcontrib>MONSALVATJE LLAGOSTERA MONTSERRAT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GASANZ GUILLEN YOLANDA</au><au>TALAVERA ESCASANY PEDRO</au><au>MONSALVATJE LLAGOSTERA MONTSERRAT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESS FOR THE PURIFICATION OF MONTELUKAST</title><date>2011-06-30</date><risdate>2011</risdate><abstract>It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic solvent and water at specific ranges of pH and temperature which depend on the type of impurities to remove. In particular, it comprises at least one wash of an aqueous phase containing crude Montelukast in salt form with an organic solvent, at a pH comprised between 12.0 and 13.5; and optionally one or more washes of the resulting aqueous phase with an organic solvent at a pH comprised between 8.5 and 10.0. Montelukast is recovered by acidification at a pH comprised between 4.5 and 8.0 and solvent extraction, and is isolated either as acid or in salt form.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI2066638TT1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PROCESS FOR THE PURIFICATION OF MONTELUKAST
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GASANZ%20GUILLEN%20YOLANDA&rft.date=2011-06-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2066638TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true